Skip to main content
. 2014 Sep 24;92(12):858–867. doi: 10.2471/BLT.14.137315

Fig. 2.

Cost–effectiveness of pulse oximetry as a function of baseline anaesthetic-related mortality

DALY: disability-adjusted life-year; GDP: gross domestic product; US$: United States dollars.

Note: The cost–effective thresholds were for the year 2013. Attractive interventions were based on the World development report 1993.38 Cost–effective interventions were based on World Health Organization guidelines, with very cost–effective and cost–effective interventions below one (US$ 677) and three (US$ 2031) times the GDP per capita for the group of low-income countries, respectively7,39

The base case,14 lower bound14 and upper bound17 report levels of the baseline anaesthetic-related mortality that occurs – or might occur – in the absence of pulse oximetry.

Fig. 2